BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 20506295)

  • 1. CHI3L1 (YKL-40) is expressed in human gliomas and regulates the invasion, growth and survival of glioma cells.
    Ku BM; Lee YK; Ryu J; Jeong JY; Choi J; Eun KM; Shin HY; Kim DG; Hwang EM; Yoo JC; Park JY; Roh GS; Kim HJ; Cho GJ; Choi WS; Paek SH; Kang SS
    Int J Cancer; 2011 Mar; 128(6):1316-26. PubMed ID: 20506295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High CHI3L1 expression is associated with glioma patient survival.
    Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
    Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental anti-angiogenesis causes upregulation of genes associated with poor survival in glioblastoma.
    Saidi A; Javerzat S; Bellahcène A; De Vos J; Bello L; Castronovo V; Deprez M; Loiseau H; Bikfalvi A; Hagedorn M
    Int J Cancer; 2008 May; 122(10):2187-98. PubMed ID: 18092325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of p-Smad2 contributes to FAT10-induced oncogenic activities in glioma.
    Dai B; Zhang Y; Zhang P; Pan C; Xu C; Wan W; Wu Z; Zhang J; Zhang L
    Tumour Biol; 2016 Jul; 37(7):8621-31. PubMed ID: 26733179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-584-3p, a novel tumor suppressor and prognostic marker, reduces the migration and invasion of human glioma cells by targeting hypoxia-induced ROCK1.
    Xue H; Guo X; Han X; Yan S; Zhang J; Xu S; Li T; Guo X; Zhang P; Gao X; Liu Q; Li G
    Oncotarget; 2016 Jan; 7(4):4785-805. PubMed ID: 26715733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiRNA expression profiling in human gliomas: upregulated miR-363 increases cell survival and proliferation.
    Conti A; Romeo SG; Cama A; La Torre D; Barresi V; Pezzino G; Tomasello C; Cardali S; Angileri FF; Polito F; Ferlazzo G; Di Giorgio R; Germanò A; Aguennouz M
    Tumour Biol; 2016 Oct; 37(10):14035-14048. PubMed ID: 27495233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-656 inhibits glioma tumorigenesis through repression of BMPR1A.
    Guo M; Jiang Z; Zhang X; Lu D; Ha AD; Sun J; Du W; Wu Z; Hu L; Khadarian K; Shen J; Lin Z
    Carcinogenesis; 2014 Aug; 35(8):1698-706. PubMed ID: 24480809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasion of human glioma cells is regulated by multiple chloride channels including ClC-3.
    Lui VC; Lung SS; Pu JK; Hung KN; Leung GK
    Anticancer Res; 2010 Nov; 30(11):4515-24. PubMed ID: 21115901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lentivirus-mediated silencing of HSDL2 suppresses cell proliferation in human gliomas.
    Ruokun C; Yake X; Fengdong Y; Xinting W; Laijun S; Xianzhi L
    Tumour Biol; 2016 Nov; 37(11):15065-15077. PubMed ID: 27658777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gab2 expression in glioma and its implications for tumor invasion.
    Shi L; Sun X; Zhang J; Zhao C; Li H; Liu Z; Fang C; Wang X; Zhao C; Zhang X; Zhou F; Lu S; Luo R; Zhang B
    Acta Oncol; 2013 Nov; 52(8):1739-50. PubMed ID: 23231021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The putative tumor suppressor miR-524-5p directly targets Jagged-1 and Hes-1 in glioma.
    Chen L; Zhang W; Yan W; Han L; Zhang K; Shi Z; Zhang J; Wang Y; Li Y; Yu S; Pu P; Jiang C; Jiang T; Kang C
    Carcinogenesis; 2012 Nov; 33(11):2276-82. PubMed ID: 22871495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of Akt2 inhibits migration and invasion of glioma cells.
    Zhang B; Gu F; She C; Guo H; Li W; Niu R; Fu L; Zhang N; Ma Y
    Int J Cancer; 2009 Aug; 125(3):585-95. PubMed ID: 19330838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-218 inhibits glioma invasion, migration, proliferation, and cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1.
    Tu Y; Gao X; Li G; Fu H; Cui D; Liu H; Jin W; Zhang Y
    Cancer Res; 2013 Oct; 73(19):6046-55. PubMed ID: 23950210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing hypoxia-inducible factor-1alpha inhibits cell migration and invasion under hypoxic environment in malignant gliomas.
    Fujiwara S; Nakagawa K; Harada H; Nagato S; Furukawa K; Teraoka M; Seno T; Oka K; Iwata S; Ohnishi T
    Int J Oncol; 2007 Apr; 30(4):793-802. PubMed ID: 17332917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA interference against TMEM97 inhibits cell proliferation, migration, and invasion in glioma cells.
    Qiu G; Sun W; Zou Y; Cai Z; Wang P; Lin X; Huang J; Jiang L; Ding X; Hu G
    Tumour Biol; 2015 Sep; 36(10):8231-8. PubMed ID: 26002575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein tyrosine phosphatase receptor U (PTPRU) is required for glioma growth and motility.
    Zhu Z; Liu Y; Li K; Liu J; Wang H; Sun B; Xiong Z; Jiang H; Zheng J; Hu Z
    Carcinogenesis; 2014 Aug; 35(8):1901-10. PubMed ID: 24876153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA interference‑mediated knockdown of translationally controlled tumor protein induces apoptosis, and inhibits growth and invasion in glioma cells.
    Jin H; Zhang X; Su J; Teng Y; Ren H; Yang L
    Mol Med Rep; 2015 Nov; 12(5):6617-25. PubMed ID: 26328748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of glioma cell migration and invasiveness by GDF-15.
    Codó P; Weller M; Kaulich K; Schraivogel D; Silginer M; Reifenberger G; Meister G; Roth P
    Oncotarget; 2016 Feb; 7(7):7732-46. PubMed ID: 26741507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of SRPK1 in gliomas and its role in glioma cell lines viability.
    Sigala I; Tsamis KI; Gousia A; Alexiou G; Voulgaris S; Giannakouros T; Kyritsis AP; Nikolakaki E
    Tumour Biol; 2016 Jul; 37(7):8699-707. PubMed ID: 26738865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Related to testes-specific, vespid, and pathogenesis protein-1 (RTVP-1) is overexpressed in gliomas and regulates the growth, survival, and invasion of glioma cells.
    Rosenzweig T; Ziv-Av A; Xiang C; Lu W; Cazacu S; Taler D; Miller CG; Reich R; Shoshan Y; Anikster Y; Kazimirsky G; Sarid R; Brodie C
    Cancer Res; 2006 Apr; 66(8):4139-48. PubMed ID: 16618735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.